Marty Makary's resignation leaves the agency with temporary directors in three top positions, and a number of newly instituted policies with an unclear future.
FDA’s leadership void leaves biotech with renewed ‘uncertainty’
Marty Makary's resignation leaves the agency with temporary directors in three top positions, and a number of newly instituted policies with an unclear future.
Source: BioPharma Dive